FindTrial
Sign In

Clinical study for treatment of liver cancer with extracorporeal hepatic resection combined with liver autotransplantation

Clinical study for treatment of liver cancer with extracorporeal hepatic resection combined with liver autotransplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-TNRC-10000974
Enrollment
Unknown
Registered
2010-08-01
Start date
2010-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

1:extracorporeal hepatic resection combined with liver autotransplantation
2:conventional operation

Sponsors

Southwest Hospital; The Third Military University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. patients who are diagnosised as having liver cancer; 2. hepatic function: Child-Pugh grade A or ICG-R15 less than 15%; 3. tumor unresectable through conventional operation; 4. without extrahepatic tumor or lymphnode metastasis; 5. heart, lung, and kidney functions are normal, respectively.

Exclusion criteria

Exclusion criteria: 1. invasion or thrombosis in portal vein, right atrium or inferior vena cava; 2. hepatic function: Child-B or Child-C; 3. metastasis in most segment of liver or out of liver; 4. server infection, server malnutrition or have other organ diseases can not tolerate the surgery; 5. received chemotherapy and/or radiotherapy.

Design outcomes

Primary

MeasureTime frame
Survival without cancer;Survival;—

Countries

China

Contacts

Public ContactPing Bie
bieping@medmail.com.cn+86 023 68754168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026